1-1 of 1
Loic Verlingue
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose-Adjusted Rituximab Mini-CYVE (CYtarabine bolus, VEpeside and dexamethasone) for Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma Not Eligible for High Dose Therapy

Yolla EL Dakdouki, Jean-Marie Michot, MD, Julien Lazarovici, MD, Khalil Saleh, MD, David Ghez, MD PhD, Claude Chahine, MD, Loic Verlingue, Christophe Willekens, MD, Veronique Vergé, Christophe Ferme, MD, Alina Danu, MD, Vincent Ribrag, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2847.
https://doi.org/10.1182/blood.V130.Suppl_1.2847.2847
Published: 2017